Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.8 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |